Abnova
Biotechnology Research • 
9th Fl., No.108, Taiwan, Province of China • 51-100 Employees
Company overview
| Headquarters | 9th Fl., No.108, Jhouzih St., Neihu District, Taipei, 114, TW |
| Phone number | +88619098397620 |
| Website | |
| NAICS | 541714 |
| SIC | 873 |
| Keywords | Immunotherapy, Antibodies, Proteins, Kits, Antibody Pairs, Chimera Rani, Immunoprecipitation System, Lysate |
| Founded | 2002 |
| Employees | 51-100 |
| Socials |
Key Contact at Abnova
Christopher Chang
Executive Vice President
Abnova Email Formats
Abnova uses 5 email formats. The most common is {first name}{last name} (e.g., johndoe@abnova.com.tw), used 36.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@abnova.com.tw | 36.4% |
{first initial}{last name} | jdoe@abnova.com | 27.3% |
{last name} | doe@abnova.com.tw | 18.2% |
{first name} | john@abnova.com | 18.2% |
About Abnova
Abnova is the first biotech company successfully integrated the IT-style management and industrial-scale antibody manufacturing. Our goal is to have at least one antibody to every human expressed gene in human genome. In Phase I of our business plans, we vastly expand the scope and availability of antibody reagents for the research market by taking a genome-wide approach to the high throughput production of human protein and antibody. There products are marketed through a combination of E-commerce based direct sales and a multi-tiered, sales network of over 49 distributors around the world. Starting from Year 2009 to 2013, in Phase II of the business plans, we have diversified into the systems arena focusing on antibody pairs, ELISA kits and instrumentation for rare cell isolation. In Phase III, we focus on in vitro diagnostics development concentrating on non-invasive, liquid biopsies of circulating tumor cells, ctDNA, and exosomes for precision medicine. Now in Phase IV (Year 2017 and later), we have focused on drug development specializing on immunotherapy. The value-added business has set the path of company's future growth and provided opportunity for Abnova to contribute to the biotech industry at large. We welcome researchers, biotech, and pharmaceutical companies to work with us and succeed together!
Abnova revenue & valuation
| Annual revenue | $12,500,000 |
| Revenue per employee | $241,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $40,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
Abnova has 14 employees across 5 departments.
Departments
Number of employees
Funding Data
Abnova has never raised funding before.
Abnova Tech Stack
Discover the technologies and tools that power Abnova's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
PaaS
Advertising
Tag managers
Shipping carriers
Shipping carriers
JavaScript libraries
Miscellaneous
Analytics
CDN
JavaScript libraries
UI frameworks
Czechia
United States
France
South Africa
Frequently asked questions
4.8
40,000 users
